SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global In-Vitro Fertilization (IVF) Market 2013 - 2020: Market to Grow from $9.3 Bn to $21 Bn by 2020

[May 15, 2014]

Research and Markets: Global In-Vitro Fertilization (IVF) Market 2013 - 2020: Market to Grow from $9.3 Bn to $21 Bn by 2020

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/sjm73p/global_invitro) has announced the addition of the "Global In-Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020" report to their offering.

The major companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.

As per the study, the global IVF market is expected to grow at a CAGR of 11.6% between 2013 and 2020. The market revenue of $9.3 billion in 2012 is estimated to grow up to $21.6 billion by 2020. Rising rate of infertility is the key factor driving the growth of the IVF market. In additin, rising awareness has led to increase in egg donation. For instance, in the U.S., the number of egg donation cycles has increased from 11,000 in the year 2000 to 18000 in 2010. Medical tourism is providing an excellent opportunity for the growth of this market. The cost of IVF in New York is approximately around $10,000- $15,000 and the same costs up to $6000 in Thailand. Developing economies are emerging to be the most preferred destination for IVF treatments with increasing focus on advanced technologies, improving health care infrastructure and favourable health care cost.


Globally, around 30 countries have some form of Assisted Reproductive Techniques (ART) with certain limitations. Few countries such as Israel, Belgium and France offer comprehensive reimbursement schemes. Intra cytoplasmic sperm injection (ICSI) as a technique is promising significant opportunities. "ICSI has been successfully performed even in complex situations where there are multiple factors responsible for infertility among both male or/and female patients. Moreover, this has been best suitable for those who have had repeated failure through conventional IVF procedure." quote Debbie Shields and Rohini Patil.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global IVF Market Overview

Chapter 4 Global IVF Market By Instruments

Chapter 5 Global IVF Market By Reagents And Media

Chapter 6 Global IVF Market By Technology

Chapter 7 Global IVF Market By End Users

Chapter 8 IVF Market By Geography

Chapter 9 Company Profiles

  • Auxogyn Inc
  • Cook Medical Inc
  • Cooper Surgical Inc.
  • EMD Serono Inc
  • Genea Biomedx
  • Irvine scientific
  • Ovascience
  • Oxford Gene Technology
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB

For more information visit http://www.researchandmarkets.com/research/sjm73p/global_invitro


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.